日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Baby formula

China's mums key to Nestle baby milk deal

(Agencies) Updated: 2012-04-25 11:19

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 中文字幕av在线 | 成人福利在线观看 | 91tv国产成人福利 | 成年人在线观看免费视频 | 亚洲美女一区 | 亚洲啪啪网 | 综合第一页 | 国产免费片| 成人欧美一区二区三区白人 | 精品国产乱码久久久 | 91欧美日韩 | 麻豆视频在线观看免费网站黄 | av一二三四| 美国黄色a级片 | 午夜久久网 | 成年免费视频黄网站在线观看 | 久久伊人成人网 | 中文字幕久久久久 | 五月天堂网 | 欧美精品中文 | 国产区精品视频 | 日韩国产三级 | 日韩一区在线播放 | 激情五月婷婷网 | 国产精品一区二区视频 | 午夜天堂| 国产在线播放91 | 色网免费 | 日韩欧美亚 | 免费黄色一级 | 人人艹视频 | 超碰97人人爱| 狠狠干网 | 日韩久久精品视频 | 毛片视频网站 | 欧美丰满一区二区免费视频 | 波多野结衣在线观看一区二区三区 | 少妇性高潮视频 | 中文字幕观看在线 | 亚洲成人三区 | va在线|